Hideki Shimodaira
Sendai, 9838512, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Risk modifiers of immune-related adverse events in patients with NSCLC undergoing immunotherapy: a retrospective cohort study.
Journal: Journal of pharmaceutical health care and sciences
Published: February 17, 2026
Japanese society for cancer of the colon and rectum (JSCCR) guidelines 2024 for the clinical practice of hereditary colorectal cancer.
Journal: International journal of clinical oncology
Published: May 21, 2025
Correction to: Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022.
Journal: Clinical and experimental nephrology
Published: December 09, 2023
Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022.
Journal: Clinical and experimental nephrology
Published: September 21, 2023
Chapter 3: Management of kidney injury caused by cancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022.
Journal: International journal of clinical oncology
Published: May 22, 2023
Isotropy of Cosmic Rays beyond 10^{20} eV Favors Their Heavy Mass Composition.
Journal: Physical review letters
Published: March 24, 2023
Phase II study of biweekly cetuximab plus mFOLFOX6 or mFOLFIRI as second-line treatment for metastatic colorectal cancer and exploratory analysis of associations between DNA methylation status and the efficacy of the anti-EGFR antibody: T-CORE1201.
Journal: Journal of gastrointestinal oncology
Published: September 09, 2022
Cisplatin Plus Capecitabine After Adjuvant S-1 in Metastatic Gastric Cancer: A Phase II T-CORE1102 Trial.
Journal: Anticancer research
Published: January 26, 2022
Phase II Study of the Reuse of Trastuzumab with Docetaxel beyond Progression after First-Line Treatment in Second-Line Treatment for Unresectable, Metastatic Gastric Cancer (T-CORE1203).
Journal: The Tohoku journal of experimental medicine
Published: May 31, 2021
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2020 for the Clinical Practice of Hereditary Colorectal Cancer.
Journal: International journal of clinical oncology
Published: December 23, 2020
Phase II study of trifluridine/tipiracil (TAS-102) therapy in elderly patients with colorectal cancer (T-CORE1401): geriatric assessment tools and plasma drug concentrations as possible predictive biomarkers.
Journal: Cancer chemotherapy and pharmacology
Published: November 23, 2020
Intermittent Withdrawal of Oxaliplatin for Alleviating Neurotoxicity during Oxaliplatin-Based Chemotherapy for Japanese Patients with Inoperable or Metastatic Colorectal Cancer: A Phase 2 Multicenter Study.
Journal: The Tohoku journal of experimental medicine
Published: May 11, 2018
Last Updated: 09/26/2026